New York, NY – February 9, 2026 — HITLAB today announced that its partner Rewire DTX, a digital therapeutics company advancing game-based cognitive interventions for depression, has successfully closed a bridge financing round, marking a pivotal step toward clinical deployment and scale. The funding provides Rewire DTX with critical runway to advance product development, complete key clinical validation milestones and prepare for pilot deployments with healthcare partners. The round reflects growing confidence in Rewire’s differentiated scientific approach to measuring and modifying depressive cognitive patterns through adaptive gameplay. As part of this next phase of growth, Rewire DTX has appointed Dr. Austin Peck as Director of Product. Dr. Peck brings deep experience translating complex technical and cognitive systems into scalable, user-centered products. He will lead product strategy, roadmap execution, and cross-functional integration as Rewire transitions from advanced prototype to pilot-ready digital therapeutic. “This bridge round is a meaningful inflection point for Rewire DTX,” said Nejeed Kassam, CEO and Co-Founder. “It enables us to sustain momentum while we convert cognitive modeling research into a clinically grounded, scalable therapeutic platform. With this capital, we are positioned to move decisively toward real-world deployment.”